1,2,4-triazine has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Guo, S; Shen, J; Wang, K; Wang, X; Xie, X; Xiong, M; Xu, T; Yun, Y; Zhao, T | 1 |
| Alhowail, A; Ali, M; Chigurupati, S; Khan, KM; Perveen, S; Salar, U; Shamim, S; Taha, M; Ullah, N; Ur Rehman, A; Wadood, A | 1 |
2 other study(ies) available for 1,2,4-triazine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Discovery of Novel 5,6-Dihydro-1,2,4-triazine Derivatives as Efficacious Glucagon-Like Peptide-1 Receptor Agonists.
Topics: Animals; Diabetes Mellitus, Type 2; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Mice; Obesity | 2023 |
Synthesis and screening of (E)-3-(2-benzylidenehydrazinyl)-5,6-diphenyl-1,2,4-triazine analogs as novel dual inhibitors of α-amylase and α-glucosidase.
Topics: Acarbose; alpha-Amylases; alpha-Glucosidases; Diabetes Mellitus, Type 2; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Triazines | 2020 |